Bladder Disorders

Disease State Hub

FDA Alerts

FDA Alert

FDA Approves Mitomycin Intravesical Solution for Recurrent Non-Muscle Invasive Bladder Cancer

06/20/2025

Miranda Manier, BA

The FDA has approved mitomycin intravesical solution for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.

06/20/2025

Research Summaries

FDA Alert

FDA Approves Mitomycin Intravesical Solution for Recurrent Non-Muscle Invasive Bladder Cancer

06/20/2025

Miranda Manier, BA

The FDA has approved mitomycin intravesical solution for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.

06/20/2025

Conference Coverage

Case-based Approaches to Diagnostic Radiology

04/26/2023

Anthony Calabro, MA

In their presentation at the 48th ONS Congress, in San Antonio, Texas, Kathy Waitman DNP, APN-BC, AOCNP and Shaunna Kersten CNS, MSN, ANP identified the best imaging modalities based on common oncologic...

04/26/2023

Urinary Incontinence

Group vs Individual Pelvic Floor Muscle Training for Urinary Incontinence

10/09/2020

A recent study examined whether group-based pelvic floor muscle training was as effective as individual PFMT for the treatment of urinary incontinence in older women.

10/09/2020

Supplements

Study Links Low Vitamin D Levels to Greater Bladder Cancer Risk

11/11/2016

Research presented at the Society for Endocrinology Conference found a connection between low levels of vitamin D and higher risk of bladder cancer.

11/11/2016

April 2026

Current Issue

April 2026